Treatment with the C5aR1 antagonist PMX205 slowed disease progression in a model of ALS in both mice and rats, delaying decline of grip strength and prolonging survival compared with vehicle-treated animals [97, 99]. The gene discussed is C5AR1; the disease is amyotrophic lateral sclerosis.